Josh Wolfe explores the broader implications of COVID-19 and what a path forward might look like. As Founder & Managing Director of Lux Capital, Josh invests in people who are inventing the future, like pioneers in the fields of nuclear waste clean up, metamaterials, satellites, and flying robots.
company.co
__
Josh Wolfe is a Co-Founder & Managing Director of VC fund Lux Capital, in NYC and Palo Alto investing in people, inventing the future. Josh focuses on contrarian investments in emerging technology. He’s a Co-Founder and Director at Kurion (doing high-tech nuclear waste in both Fukushima and US nuclear weapons cleanup complexes); at Kymeta (as Founding Investor and Director with Bill Gates and Nathan Myhrvold commercializing “metamaterials” for global satellite communications); at Shapeways (the world leader in 3d printing). Others include Planet Labs (which in 2014 launched the largest constellation of earth-imaging satellites) CyPhy(MIT-spawned flying commercial and military robots) Siluria (MIT-spinout converting natural gas to global chemicals) and Matterport (rapid 3D scanning). Current pursuits are computational imaging and sound, digital pathology, high-tech tattoo removal, and flavors & fragrances. Josh previously worked at SalomonSmithBarney and Merrill Lynch and published AIDS-immunopathology research in Cell Vision & The Journal of Leukocyte Biology. He’s a term member at the Council on Foreign Relations and a columnist and editor with Forbes. Josh is Co-Founder & Chairman of Coney Island Prep, a charter school in his native Coney Island, Brooklyn where he believes inner-city scholars need the right heroes and a deep desire to learn.